Your browser doesn't support javascript.
loading
Local irradiation does not enhance the effect of immunostimulatory AdCD40L gene therapy combined with low dose cyclophosphamide in melanoma patients.
Irenaeus, Sandra; Schiza, Aglaia; Mangsbo, Sara M; Wenthe, Jessica; Eriksson, Emma; Krause, Johan; Sundin, Anders; Ahlström, Håkan; Tötterman, Thomas H; Loskog, Angelica; Ullenhag, Gustav J.
Afiliação
  • Irenaeus S; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 751 85, Uppsala, Sweden.
  • Schiza A; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden.
  • Mangsbo SM; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 751 85, Uppsala, Sweden.
  • Wenthe J; Department of Oncology, Uppsala University Hospital, 751 85, Uppsala, Sweden.
  • Eriksson E; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 751 85, Uppsala, Sweden.
  • Krause J; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 751 85, Uppsala, Sweden.
  • Sundin A; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, 751 85, Uppsala, Sweden.
  • Ahlström H; Department of Radiology, Uppsala University Hospital, 751 85, Uppsala, Sweden.
  • Tötterman TH; Department of Radiology, Uppsala University Hospital, 751 85, Uppsala, Sweden.
  • Loskog A; Department of Surgical Sciences, Uppsala University, 751 85, Uppsala, Sweden.
  • Ullenhag GJ; Department of Radiology, Uppsala University Hospital, 751 85, Uppsala, Sweden.
Oncotarget ; 8(45): 78573-78587, 2017 Oct 03.
Article em En | MEDLINE | ID: mdl-29108250

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2017 Tipo de documento: Article